Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Immune Response Following Surgical Management of Renal Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00289146
Recruitment Status : Terminated
First Posted : February 9, 2006
Last Update Posted : September 24, 2013
Sponsor:
Information provided by (Responsible Party):
Kenneth Ogan, MD, Emory University

Tracking Information
First Submitted Date February 7, 2006
First Posted Date February 9, 2006
Last Update Posted Date September 24, 2013
Study Start Date November 2005
Actual Primary Completion Date August 2006   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures Not Provided
Original Primary Outcome Measures Not Provided
Change History
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Comparison of Immune Response Following Surgical Management of Renal Tumors
Official Title Comparison of Immune Response Following Surgical Management of Renal Tumors
Brief Summary Examine the effects of renal surgery on the immune system.
Detailed Description Prospective study examining the effects of different surgical procedures on immune function. This may have bearing on overall cancer specific recurrence and survival.
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Retention:   Samples Without DNA
Description:
Blood samples
Sampling Method Probability Sample
Study Population Patients undergoing open or laparoscopic surgeries for the treatment of kidney tumors.
Condition Kidney Cancer
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Terminated
Estimated Enrollment
 (submitted: February¬†7,¬†2006)
50
Original Enrollment Same as current
Actual Study Completion Date August 2006
Actual Primary Completion Date August 2006   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Kidney tumor patients scheduled for open or laparoscopic surgery

Exclusion Criteria:

-

Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT00289146
Other Study ID Numbers 0021-2005
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Kenneth Ogan, MD, Emory University
Study Sponsor Emory University
Collaborators Not Provided
Investigators
Principal Investigator: Kenneth Ogan, MD Emory University
PRS Account Emory University
Verification Date September 2013